Fundamental Analysis of Abeona Therapeutics Inc - Growth / Value Index


ABEO - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 5.00
   Price to Book Ratio of 869.54 suggesting that it is very expensive
   Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -302.12 -0.886 -9650.54 %
Price to Book 1125.38 1.44 9481.99 % 5.51
Price to Sales 4227.46 27.24 10489.56 %
Enterprise Value to EBITDA Multiple -1.56 -0.683 -272.92 %


ABEO - Profitability Highlights

Profitability Analysis

   Reasonable Dividend Yield of 3.82 %
   Tsr Profitability Index - Very Poor Score of 5.00
   Piotroski F Score - Very Poor Value of 1.0
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity -372.50 -162.47 1.73 % -53.71
Return On Asset -124.59 -67.71 36.56 % -17.91
Net Profit Margin -1399.29 -3074.82 -8.60 % 0
Operating Profit Margin -1478.04 -3600.78 -20.25 % 0
EBITDA Margin -1421.37 -2699.08 -5.43 % 0


Highlights
Market Cap121389 K
Enterprise Value108945 K
Price/Book TTM1125.38
Outstanding Share24773.30 K
Float/ Outstanding Share71.77%
Dividend Yield3.82 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score1.0
Altman Z Score-14.54
Sloan Ratio0.0001
Peter Lynch Fair Value0


ABEO - Growth Highlights

Growth Analysis

   Tsr Growth Index - Poor Score of 24.05
   Companies' sales dropped by 52.87 % from last year
   Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 4914.00 K 52.87 % 100.00 %
Gross Profit 4784.00 K 67.87 % 100.86 %
EBITDA -69846.00 K 50.31 % 31.52 %
Net Profit -68761.00 K 48.81 % 28.93 %
EPS -0.0162 98.97 % NA


ABEO - Stability Highlights

Stability Analysis

   Cash ratio of 6.70
   Company financial liquidity has improved
   Tsr Stability Index - Poor Score of 29.69
   Altman Z Score of -15.02 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -58.07
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.066 87.23 % 0.075
Cash Ratio 6.70 147.51 %
Quick Ratio 6.78 0 % 6.77
Shareholders Equity 41.67 -35.44 %
Debt to EBITDA -0.0465 -96.26 %


Historical Valuation Ratios of Abeona Therapeutics Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Abeona Therapeutics Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Abeona Therapeutics Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Abeona Therapeutics Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)